A. Ketring

发表

Development of an in vitro model for assessing the in vivo stability of lanthanide chelates.

S. Jurisson, C. Cutler, T. Hoffman, 2001, Nuclear medicine and biology.

The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine.

J. Vanderheyden, H. Maxon, A. Ketring, 1986, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Calculation of radiation dose at a bone-to-marrow interface using Monte Carlo modeling techniques (EGS4)

S. Loyalka, W. Volkert, A. Ketring, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability.

S. Jurisson, C. Cutler, C. Barnes, 2018, Nuclear medicine and biology.

Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats.

L. A. Ochrymowycz, M. Abrams, J. Vollano, 1997, Nuclear medicine and biology.

Chromatographic separation of selenium and arsenic: A potential (72)Se/(72)As generator.

S. Jurisson, C. Cutler, N. Sisay, 2014, Journal of chromatography. A.

Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.

J. Hewett, G. J. Ehrhardt, W. Volkert, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.

S. Anderson, G. J. Ehrhardt, W. Volkert, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A new 99mTc-complex with a germanium-hydrazide (GeTH) ligand.

K. Katti, K. Katti, W. Volkert, 1994, Nuclear medicine and biology.

A new neutral-lipophilic 99mTc complex with a bis-hydrazide-phosphine (BHP) ligand

K. Katti, K. Katti, W. Volkert, 1992 .

Rhodium-105 complexes as potential radiotherapeutic agents

S. Jurisson, W. Volkert, A. Ketring, 1997 .

with Samarium-153-EDTMP Clinical and Clinicopathologic Response of Canine Bone Tumor Patients to Treatment

Anderson, G. J. Ehrhardt, W. Volkert, 2006 .

Aminocarboxylate complexes and octreotide complexes with no carrier added 177Lu, 166Ho and 149Pm.

S. Jurisson, C. Cutler, T. Hoffman, 2003, Nuclear medicine and biology.

Complexing of Tc-99m with cyclam: concise communication.

R. A. Holmes, W. Volkert, A. Ketring, 1980, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radiolanthanide-labeled monoclonal antibody CC49 for radioimmunotherapy of cancer: biological comparison of DOTA conjugates and 149Pm, 166Ho, and 177Lu.

S. Jurisson, C. Cutler, T. Hoffman, 2006, Bioconjugate chemistry.

Production of radiolanthanides and radiotherapy research at MURR

G. J. Ehrhardt, A. Ketring, D. Ma, 1996 .

The Noah's Ark experiment: species dependent biodistributions of cationic 99mTc complexes.

W. Hirth, J. Vanderheyden, A. Ketring, 1989, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Evaluation of 72Se/72As generator and production of 72Se for supplying 72As as a potential PET imaging radionuclide.

Ashley F. Berendzen, S. Jurisson, C. Cutler, 2019, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Dosimetric implications of the potential radionuclidic impurities in 153Sm-DOTMP

A. Ketring, R. K. Frank, Richard E. Wendt, 2022, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Bulk production and evaluation of high specific activity 186gRe for cancer therapy using enriched 186WO3 targets in a proton beam.

F. M. Nortier, Heather M. Hennkens, S. Jurisson, 2017, Nuclear medicine and biology.

186Re/188Re labeled polypeptide microspheres as a potential radiation synovectomy agent

K. Zinn, G. J. Ehrhardt, A. Ketring, 1996 .

Therapeutic radionuclides: production and decay property considerations.

W A Volkert, G. J. Ehrhardt, W. Volkert, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals.

A. Ketring, 1987, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Reactor-produced radionuclides at the University of Missouri Research Reactor.

G. J. Ehrhardt, A. Ketring, G J Ehrhardt, 1998, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.

R. A. Holmes, W. Volkert, A. Ketring, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chemistry in Environmentally Benign Media. 7.1 Chelating Hydroxymethyl-Functionalized Bisphosphines as Building Blocks to Water-Soluble and in-Vitro-Stable Gold(I) Complexes. Synthesis, Characterization, and X-ray Crystal Structures of [Au{(HOH2C)2PC6H4P(CH2OH)2}2]Cl and [Au2{(HOH2C)2PCH2CH2P(CH2OH)

K. Katti, C. Barnes, W. Volkert, 1997 .

Dithiol Aryl Arsenic Compounds as Potential Diagnostic and Therapeutic Radiopharmaceuticals.

S. Jurisson, C. Cutler, C. Barnes, 2016, Inorganic chemistry.

198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals.

K. Katti, W. Volkert, C. Higginbotham, 1998, Nuclear medicine and biology.

Biodistribution of lipophilic 99mTc complexes of cyclam derivatives.

R. A. Holmes, T. Hoffman, W. Volkert, 1984, International journal of nuclear medicine and biology.

Chemistry in Environmentally Benign Media. 3.1 Synthesis and Characterization of Rhenium(V) Complexes Derived from Novel Water-Soluble (Hydroxymethyl)phosphines. Crystal Structures of [Re(O)2{(HOH2C)2PC6H4P(CH2OH)2}2]I and [Re(O)2{(HOH2C)2PCH2CH2P(CH2OH)2}2]Cl

K. Katti, C. Barnes, W. Volkert, 1996 .

Synthesis and characterization of cationic technetium complexes of 1,2-bis(dimethylphosphino)ethane (DMPE). Structure determinations of trans-[TcV(DMPE)2(OH)(O)](F3CSO3)2, trans-[TcIII(DMPE)2Cl2]F3CSO3, and [TcI(DMPE)3]+ using x-ray diffraction, EXAFS, and technetium-99 NMR

J. Vanderheyden, A. Ketring, E. Deutsch, 1984 .

Synthesis and characterization of a neutral and lipophilic Ph3PN99mTcO3 complex

M. Welch, K. Katti, K. Katti, 1995 .

186Re-HEDP: a potential therapeutic bone agent.

A. Ketring, J. Weininger, E. A. Deutsch, 1984, Nuklearmedizin. Nuclear medicine.

Radioisotope radiotherapy research and achievements at the University of Missouri Research Reactor

C. Cutler, G. J. Ehrhardt, A. Ketring, 2003 .

J. Vanderheyden, A. Ketring, E. Deutsch, 1990 .

Comparison of Systemic Toxicities of 177Lu-DOTMP and 153Sm-EDTMP Administered Intravenously at Equivalent Skeletal Doses to Normal Dogs

C. Cutler, J. Bryan, A. Ketring, 2009, Journal of Nuclear Medicine Technology.

Radiochemical Study of Re/W Adsorption Behavior on a Strongly Basic Anion Exchange Resin

S. Jurisson, J. Engle, C. Cutler, 2014 .

Biological comparison of 149Pm-, 166Ho-, and 177Lu-DOTA-biotin pretargeted by CC49 scFv-streptavidin fusion protein in xenograft-bearing nude mice.

S. Jurisson, C. Cutler, A. Ketring, 2004, Nuclear medicine and biology.

Chemistry and radiochemistry of As, Re and Rh isotopes relevant to radiopharmaceutical applications: high specific activity radionuclides for imaging and treatment.

Heather M. Hennkens, S. Jurisson, C. Barnes, 2017, Dalton transactions.

Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals.

S. Jurisson, C. Cutler, C. Barnes, 2016, Nuclear medicine and biology.

Scale-up of high specific activity 186gRe production using graphite-encased thick 186W targets and demonstration of an efficient target recycling process

Bennett E. Smith, S. Jurisson, P. Pauzauskie, 2017 .

RADIOLABELED PHOSPHONIC ACID CHELATES: POTENTIAL THERAPEUTIC AGENTS FOR TREATMENT OF SKELETAL METASTASES

R. A. Holmes, W. Volkert, A. Ketring, 1989 .

Effect of Stoichiometric and Preparation Parameters on W-188/Re-188 Gel Generator Performance

R. Miller, G. J. Ehrhardt, A. Ketring, 1997 .

Deuteron irradiation of W and WO3 for production of high specific activity (186)Re: Challenges associated with thick target preparation.

Bennett E. Smith, S. Jurisson, P. Pauzauskie, 2016, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Accelerator-based production of the (99m)Tc-(186)Re diagnostic-therapeutic pair using metal disulfide targets (MoS2, WS2, OsS2).

Bennett E. Smith, S. Jurisson, P. Pauzauskie, 2016, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu.

S. Jurisson, C. Cutler, W. Miller, 2011, Bioconjugate chemistry.

Phase I evaluation of CycloSam® (Sm-153-DOTMP) bone seeking radiopharmaceutical in dogs with spontaneous appendicular osteosarcoma.

R. Wendt, K. Keegan, J. Bryan, 2023, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Comparison of pretargeted and conventional CC49 radioimmunotherapy using 149Pm, 166Ho, and 177Lu.

S. Jurisson, A. Ketring, J. Simón, 2011, Bioconjugate chemistry.

An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates.

S. Jurisson, C. Barnes, W. Volkert, 1996, Nuclear medicine and biology.